A drug in development and undergoing clinical trials could be considered prohibited if it falls into one of the categories of banned substances on the WADA Prohibited List, or if it has the potential to be performance enhancing
Glutamine withdrawal, but not inhibition of glutaminolysis, results in loss of c-Myc protein, reduced cell growth, and impaired NK cell responses 138
Experimental studies suggest that liraglutide exerts its anorexigenic but not hypoglycemic effects through CNS receptors, rather than through vagus nerve receptors [25]
doi: 10.3390/antiox10020313 33 ZengFShiYWuCLiangJZhongQBrileyKet al
Eligible participants were required to have no history with drug use, psychiatric or neurological illnesses, heart conditions, high blood pressure, pregnancy and glaucoma
Those with type 2 diabetes seeking glycemic control